Clinical Trials on Fluorescence In Situ Hybridization

Total 1185 results

Maastricht University Medical Center

Withdrawn

Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study

Chromosomal Instability | Low Grade Dysplasia Oral Cavity | Loss of Heterozygostiy | Fluorescence In Situ Hybridization

Netherlands
Medical University of Vienna

Recruiting

The Effect of Hyperoxia and Hypoxia on Fluorescence Lifetime Imaging Ophthalmoscopy in Healthy Subjects- a Randomized, Double Blind, Crossover Study

To Investigate the Effect of 100% Oxygen Breathing on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Healthy Subjects

Austria
University of Texas Southwestern Medical Center

Completed

Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved

Breast Cancer in Situ
Meander Medical Center

Completed

Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW (IBIZA-2)

Colorectal Neoplasms | Sentinel Lymph Node | Colon Neoplasm | Fluorescence

Netherlands
Meander Medical Center

Completed

Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW. (IBIZA-1)

Colorectal Neoplasms | Colonic Neoplasms | Sentinel Lymph Node | Fluorescence

Netherlands
Saint John's Cancer Institute

Recruiting

Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

Breast Neoplasms | Early-stage Breast Cancer | Breast Carcinoma in Situ

United States
Medical College of Wisconsin

Active, not recruiting

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Breast Cancer | Breast Neoplasms | Breast Cancer Stage IV | Breast Adenocarcinoma | Breast Cancer Stage | Breast Cancer Invasive | Breast Cancer in Situ

United States
XEOS Medical

Recruiting

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer (BrIMA)

Breast Cancer | Breast Cancer Invasive | Breast Cancer in Situ

Belgium
University of California, San Francisco
Patient-Centered Outcomes Research Institute; National Cancer Institute (NCI); United States Department of Defense and other collaborators

Recruiting

Women Informed to Screen Depending on Measures of Risk (Wisdom Study) (WISDOM)

Breast Cancer | Breast Cancer Screening | Breast Carcinoma in Situ

United States
M.D. Anderson Cancer Center

Completed

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Ductal Carcinoma In Situ

United States
Uppsala University
Royal Marsden NHS Foundation Trust; Uppsala University Hospital; Westmead Breast... and other collaborators

Recruiting

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) (OncoPROValue-1)

Breast Cancer | Breast Carcinoma in Situ | Breast Cancer Invasive | Breast Asymmetry

United Kingdom, Sweden, Australia
National Institute of Oncology, Hungary

Unknown

Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study

Invasive Breast Cancer | in Situ Breast Cancer

Hungary
Dana-Farber Cancer Institute
Myriad Genetics, Inc.

Active, not recruiting

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Breast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast Cancer

United States
Aarhus University Hospital
Danish Cancer Society; The Korning foundation; Foundation of the Kjaersgaard... and other collaborators

Completed

Immediate Breast Reconstruction With Acellular Dermal Matrix

Breast Cancer | Mammaplasty | Breast Carcinoma in Situ | Acellular Dermis
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Active, not recruiting

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Ductal Carcinoma in Situ of the Breast

United States
Istituto Oncologico Veneto IRCCS

Recruiting

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management

Pleomorphic Lobular Breast Carcinoma in Situ | Breast Florid Lobular Carcinoma in Situ

Italy
Allegheny Singer Research Institute (also known...

Recruiting

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Breast Cancer | Breast Cancer Female | Breast Carcinoma in Situ

United States
Brust-Zentrum AG

Not yet recruiting

Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer in Situ
Sunnybrook Health Sciences Centre
University of Toronto; Sunnybrook Research Institute

Completed

Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

Rectal Neoplasm Carcinoma in Situ Adenocarcinoma

Canada
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

Breast Cancer
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
Northwestern University
National Cancer Institute (NCI); Pfizer; University of California, San Francisco and other collaborators

Recruiting

The PROMISE Study: Duavee in Women With DCIS

Postmenopausal | Ductal Breast Carcinoma In Situ

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Active, not recruiting

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Ductal Breast Carcinoma In Situ

United States
Institut Bergonié

Completed

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast (CINNAMOME)

Intraductal Carcinoma and Lobular Carcinoma in Situ

France
Liao Ning

Recruiting

Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer

Breast Neoplasms

China
Northwestern University
National Cancer Institute (NCI)

Recruiting

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Cancer Survivor | Invasive Breast Carcinoma | Ductal Breast Carcinoma In Situ

United States
Stanford University

Recruiting

Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma (NORDIS)

Ductal Breast Carcinoma in Situ

United States
Clinical Hospital Center Rijeka

Not yet recruiting

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS (CEMinDCIS)

DCIS | Breast Carcinoma in Situ | Calcification

Croatia
Northwestern University
National Cancer Institute (NCI); BHR Pharma, LLC

Recruiting

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Estrogen Receptor Positive | Ductal Breast Carcinoma In Situ

United States
National Cancer Institute (NCI)

Completed

Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ

HER2/Neu Positive | Ductal Breast Carcinoma In Situ

United States
Northwestern University
National Cancer Institute (NCI)

Completed

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Estrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in Situ

United States
The University of Hong Kong
Food and Health Bureau, Hong Kong Government

Active, not recruiting

Hong Kong Breast Cancer Study

Breast Cancer | Ductal Carcinoma In Situ

Hong Kong
Dartmouth-Hitchcock Medical Center
Hologic, Inc.

Completed

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

Invasive Breast Cancer | Ductal Carcinoma In Situ

United States
University of Wisconsin, Madison
National Cancer Institute (NCI); National Center for Advancing Translational...

Completed

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Breast Cancer | Ductal Carcinoma in Situ - Category

United States
Eli Avisar

Withdrawn

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

Breast Cancer | Invasive Breast Carcinoma | Ductal Carcinoma In-situ
Sidney Kimmel Comprehensive Cancer Center at Johns...
BioSante Pharmaceuticals; David H. Koch Charitable Foundation

Completed

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Prostate Cancer Adenocarcinoma in Situ

United States
University of Aarhus
Danish Cancer Society

Completed

Shoulder Disability and Late Symptoms Following Oncoplastic Breast Surgery

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Completed

Oxybutynin Chloride in Managing Hot Flashes

Hot Flashes | Breast Carcinoma | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | No Evidence of Disease

United States
Thomas Jefferson University

Recruiting

Prospective Breast Cancer Biospecimen Collection

Breast Cancer | Invasive Breast Cancer | Carcinoma in Situ of the Breast

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Breast Ductal Carcinoma In Situ

United States, Canada, Puerto Rico, Korea, Republic of
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast (DCIS)

Carcinoma Breast

Italy
National Cancer Institute (NCI)

Completed

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

Healthy, no Evidence of Disease | Lobular Breast Carcinoma in Situ

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Breast Cancer

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Atypical Hyperplasia of the Breast | Lobular Breast Carcinoma In Situ | Pleomorphic Lobular Breast Carcinoma In Situ

United States, Guam
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ

United States
Cancer Institute and Hospital, Chinese Academy...
Shanxi Province Cancer Hospital; Guangdong Provincial Hospital of Traditional... and other collaborators

Not yet recruiting

Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer (FLORA-01)

Colorectal Neoplasms | Fluorescence | Lymph Node Excision

China
University Hospital Tuebingen

Recruiting

Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )

Breast Carcinoma | Breast Carcinoma in Situ

Germany
Atossa Therapeutics, Inc.

Terminated

A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant (007)

Female Breast Carcinoma | Female Ductal Carcinoma In Situ

United States
University of Southern California

Terminated

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Breast Ductal Carcinoma In Situ

United States

Clinical Trials on Fluorescence In Situ Hybridization

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations